Discover 1,607 paid clinical trials in Newnan, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,607
FeaturedActive & Responsive
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
for
Overweight, Prediabetic State, Prehypertension,
Location: Decatur GA, Dalton GA, Mauldin SC, St. Petersburg FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07794579
Phase 3, Recruiting
FeaturedActive & Responsive
Graves' Disease Studies for Adults Taking Antithyroid Medication
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for
Heart Failure With Preserved Ejection Fraction,
Location: Peachtree City GA, Atlanta GA, Birmingham AL,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07037459
Phase 3, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Fayetteville GA, Atlanta GA, Decatur GA, Birmingham AL,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07231419
Phase 3, Recruiting
Active & Responsive
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
for
Obesity, Overweight
Location: Union City GA, Anniston AL, Gainesville GA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07684235
Phase 3, Recruiting
Active & Responsive
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
for
Type 2 Diabetes
Location: Union City GA, Woodstock GA, Lawrenceville GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06897475
Phase 2, Recruiting
Active & Responsive
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
for
Obesity or Overweight
Location: Union City GA, Woodstock GA, Johns Creek GA, Canton GA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07575399
Phase 3, Recruiting
Active & Responsive
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
for
ADHD
Location: Union City GA, Atlanta GA, Dothan AL,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 6 - 11
Code: NCT07717879
Phase 3, Recruiting
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: Douglasville GA, Smyrna TN, Columbia SC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Phase 4, Recruiting
Active & Responsive
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
for
Sickle Cell Disease
Location: Riverdale GA, Birmingham AL, Augusta GA,